22 de junho de 2021
Compartilhe o CEER
SARS to novel coronavirus - old lessons and new lessons.

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV).

A new coronavirus associated with human respiratory disease in China.

A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins

The 2019-new coronavirus epidemic: Evidence for virus evolution.

Responding to Covid-19 — A Once-in-a-Century Pandemic?

Covid-19

Clinical Characteristics of Coronavirus

COVID-19 Treatment: A Review of Early and Emerging Options

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS, or COVID-19

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic— COVID-19 and Card

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19

Morbidity and Mortality Weekly Report

Long-term Health Consequences of COVID-19

Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Sing

Neurologic and neuroimaging findings in patients with COVID-19

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical

Genomic evidence for reinfection with SARS-CoV-2: a case study

The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subject

SARS-CoV-2–Associated Deaths Among Persons Aged <21 Years — United States, February 12–July 31, 2020

Humoral Immune Response to SARS-CoV-2 in Iceland

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally

Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therap

Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score

Acute kidney injury in patients hospitalized with COVID-19

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study

Psychiatric symptomatology associated with depression, anxiety, distress, and insomnia in health

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Thoracic imaging tests for the diagnosis of COVID-19 (Review)

The Stress of Bayesian Medicine — Uncomfortable Uncertainty in the Face of Covid-19

The Role of Market Forces in U.S. Health Care

Seizing the Teachable Moment — Lessons from Eisenhower’s Heart Attack

Lessons We’ve Learned — Covid-19 and the Undocumented Latinx Community

Improving Clinical Trial Enrollment — In the Covid-19 Era and Beyond

Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact

Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in

Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South

Clinical immunity in discharged medical patients with COVID-19

Critical illness myopathy after COVID-19

Severe immune thrombocytopenia in a critically ill COVID-19 patient

Possible intrauterine SARS-CoV-2 infection: Positive nucleic acid testing results

Patterns of viral clearance in the natural course of asymptomatic COVID-19

SARS-CoV-2-related mortality in a rural Latin American population

Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate

Time to strengthen capacity in infectious disease control at the European level

Therapeutic plasma exchange in adults with severe COVID-19 infection

An Outbreak of Covid-19 on an Aircraft Carrier

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Rapid Implementation of eMOLST Order Completion and Electronic Registry to Facilitate Advance Care P

SARS-CoV-2 in the U.S. Military — Lessons for Civil Society

SARS-CoV-2 Transmission among Marine Recruits during Quarantine

Clinical Microbiology and Infection

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiati

Different Types of Vaccines

Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young

COVID-19 e a Odontologia na prática atual

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Evaluation of Rooming-in Practice for Neonates Born to Mothers With Severe Acute Respiratory Syndrom

Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibito

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associate

The interplay between HIV and COVID-19: summary of the data and responses to date

Virologic and Immunologic Outcomes for HIV Patients With Coronavirus Disease 2019

COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohor

One year after the arrival of COVID-19 in Latin America: what have we learned in Brazil and other co

Visceral Leishmaniasis diagnosis: a rapid test is a must at the hospital bedside

Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: F

Mask related acne (“maskne”) and other facial dermatoses

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 du

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

An integrated multidisciplinary model of COVID-19 recovery care

Compartilhar